Globeflex Capital’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.5M | Hold |
15,546
| – | – | 0.23% | 122 |
|
|
2025
Q4 | $1.51M | Hold |
15,546
| – | – | 0.23% | 113 |
|
|
2025
Q3 | $1.11M | Hold |
15,546
| – | – | 0.17% | 151 |
|
|
2025
Q2 | $929K | Hold |
15,546
| – | – | 0.08% | 189 |
|
|
2025
Q1 | $816K | Hold |
15,546
| – | – | 0.08% | 199 |
|
|
2024
Q4 | $855K | Hold |
15,546
| – | – | 0.07% | 207 |
|
|
2024
Q3 | $782K | Buy |
+15,546
| New | +$717K | 0.07% | 218 |
|
|
2024
Q2 | – | Sell |
-2,034
| Closed | -$89.5K | – | 503 |
|
|
2024
Q1 | $89.5K | Hold |
2,034
| – | – | 0.01% | 406 |
|
|
2023
Q4 | $96.6K | Hold |
2,034
| – | – | 0.01% | 400 |
|
|
2023
Q3 | $90.2K | Sell |
2,034
-1,184
| -37% | -$55K | 0.01% | 390 |
|
|
2023
Q2 | $154K | Hold |
3,218
| – | – | 0.02% | 341 |
|
|
2023
Q1 | $127K | Hold |
3,218
| – | – | 0.02% | 373 |
|
|
2022
Q4 | $91K | Hold |
3,218
| – | – | 0.01% | 408 |
|
|
2022
Q3 | $97K | Sell |
3,218
-19,686
| -86% | -$686K | 0.02% | 402 |
|
|
2022
Q2 | $777K | Sell |
22,904
-3,444
| -13% | -$123K | 0.19% | 160 |
|
|
2022
Q1 | $1.18M | Hold |
26,348
| – | – | 0.24% | 119 |
|
|
2021
Q4 | $1.22M | Hold |
26,348
| – | – | 0.25% | 127 |
|
|
2021
Q3 | $885K | Buy |
26,348
+25,835
| +5,036% | +$879K | 0.19% | 173 |
|
|
2021
Q2 | $15K | Buy |
+513
| New | +$14.1K | ﹤0.01% | 420 |
|
|
2020
Q4 | – | Sell |
-18,256
| Closed | -$390K | – | 502 |
|
|
2020
Q3 | $390K | Hold |
18,256
| – | – | 0.1% | 294 |
|
|
2020
Q2 | $424K | Buy |
18,256
+2,746
| +18% | +$59K | 0.11% | 304 |
|
|
2020
Q1 | $331K | Buy |
+15,510
| New | +$369K | 0.1% | 298 |
|
|
2017
Q2 | – | Sell |
-85,151
| Closed | -$758K | – | 439 |
|
|
2017
Q1 | $758K | Buy |
85,151
+40,800
| +92% | +$378K | 0.18% | 210 |
|
|
2016
Q4 | $492K | Buy |
44,351
+7,157
| +19% | +$77.1K | 0.12% | 255 |
|
|
2016
Q3 | $632K | Buy |
37,194
+51
| +0.1% | +$944 | 0.16% | 219 |
|
|
2016
Q2 | $808K | Hold |
37,143
| – | – | 0.22% | 178 |
|
|
2016
Q1 | $712K | Hold |
37,143
| – | – | 0.19% | 186 |
|
|
2015
Q4 | $1.04M | Hold |
37,143
| – | – | 0.28% | 135 |
|
|
2015
Q3 | $905K | Buy |
37,143
+37,100
| +86,279% | +$888K | 0.19% | 179 |
|
|
2015
Q2 | $1K | Hold |
43
| – | – | ﹤0.01% | 443 |
|
|
2015
Q1 | $1K | Buy |
+43
| New | +$635 | ﹤0.01% | 444 |
|
Other funds holding IRMD
CCM
VCM
NTCM
Globeflex Capital's IRMD Position: Q1 2026 in Review
Globeflex Capital held its iRadimed (IRMD) position steady in Q1 2026 at 15,546 shares worth $1.5M. The position accounts for 0.23% of the portfolio, ranked #122.
Globeflex Capital first reported a position in IRMD in Q1 2015 and has held it in 31 quarters since. The position peaked at $1.51M in Q4 2025. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.
- Globeflex Capital held 15,546 shares of iRadimed worth $1.5M as of Q1 2026.
- Globeflex Capital left its iRadimed share count unchanged in Q1 2026.
- iRadimed made up 0.23% of Globeflex Capital's portfolio in Q1 2026, its #122 holding.
- Globeflex Capital first reported a position in iRadimed in Q1 2015 and has held it in 31 quarters since.
- Globeflex Capital's iRadimed position peaked at $1.51M in Q4 2025.
- 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.
Based on Globeflex Capital's 13F filing for Q1 2026, filed 13 May 2026.